LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple Myeloma
Clinical trial NCT03773107 · COMPLETED
Trial details
- NCT number
- NCT03773107
- Sponsor
- Wake Forest University Health Sciences
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-03
- Primary completion
- 2022-11-07
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.